These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 32675548)

  • 1. Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer.
    Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Ide S; Kitajima T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Yokoe T; Saigusa S; Tanaka K; Shirai Y; Kobayashi M; Ohi M; Araki T; McMillan DC; Miki C; Goel A; Kusunoki M
    Ann Surg; 2020 Aug; 272(2):342-351. PubMed ID: 32675548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cumulative perioperative lymphocyte/C-reactive protein ratio as a predictor of the long-term outcomes of patients with colorectal cancer.
    Okugawa Y; Toiyama Y; Fujikawa H; Kawamura M; Yasuda H; Yokoe T; Mochiki I; Okita Y; Ohi M; Nakatani K
    Surg Today; 2021 Dec; 51(12):1906-1917. PubMed ID: 33954875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer.
    Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Ichikawa T; Yin C; Suzuki A; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Ohi M; Araki T; McMillan DC; Kusunoki M
    Clin Nutr; 2020 Apr; 39(4):1209-1217. PubMed ID: 31155370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the preoperative lymphocyte to C-reactive protein ratio in patients with stage III colorectal cancer.
    Eren T
    ANZ J Surg; 2022 Oct; 92(10):2585-2594. PubMed ID: 35779019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of the preoperative lymphocyte C-reactive protein ratio in esophageal cancer patients.
    Yamamoto A; Toiyama Y; Okugawa Y; Ichikawa T; Imaoka H; Yasuda H; Fujikawa H; Okita Y; Yokoe T; Ohi M
    Surg Today; 2021 May; 51(5):745-755. PubMed ID: 33130991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.
    Chan JC; Chan DL; Diakos CI; Engel A; Pavlakis N; Gill A; Clarke SJ
    Ann Surg; 2017 Mar; 265(3):539-546. PubMed ID: 27070934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of lymph node metastasis in patients with T1-stage colorectal cancer from multiple centers in China.
    Sun ZQ; Ma S; Zhou QB; Yang SX; Chang Y; Zeng XY; Ren WG; Han FH; Xie X; Zeng FY; Sun XT; Wang GX; Li Z; Zhang ZY; Song JM; Liu JB; Yuan WT
    World J Gastroenterol; 2017 Dec; 23(48):8582-8590. PubMed ID: 29358866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum carboxypeptidaseA4 levels predict liver metastasis in colorectal carcinoma.
    Sun L; Guo C; Burnett J; Yang Z; Ran Y; Sun D
    Oncotarget; 2016 Nov; 7(48):78688-78697. PubMed ID: 27780921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.
    Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH
    BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical feasibility of the preoperative C-reactive protein-albumin-lymphocyte index to predict short- and long-term outcomes of patients with gastric cancer.
    Okugawa Y; Ohi M; Kitajima T; Higashi K; Sato Y; Yamashita S; Uratani R; Shimura T; Imaoka H; Kawamura M; Koike Y; Yasuda H; Yoshiyama S; Okita Y; Toiyama Y
    J Gastrointest Surg; 2024 Jul; 28(7):1045-1050. PubMed ID: 38641163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.
    Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Kubota K
    Ann Surg Oncol; 2012 Oct; 19(11):3422-31. PubMed ID: 22576063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment.
    Sun LC; Chu KS; Cheng SC; Lu CY; Kuo CH; Hsieh JS; Shih YL; Chang SJ; Wang JY
    BMC Cancer; 2009 Aug; 9():288. PubMed ID: 19691850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
    Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z
    BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative to positive lymph node ratio is a superior predictor than traditional lymph node status in stage III colorectal cancer.
    Li Q; Liang L; Jia H; Li X; Xu Y; Zhu J; Cai S
    Oncotarget; 2016 Nov; 7(44):72290-72299. PubMed ID: 27474167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.
    Toiyama Y; Hur K; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
    Ann Surg; 2014 Apr; 259(4):735-43. PubMed ID: 23982750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K
    Anticancer Res; 2016 Mar; 36(3):995-1001. PubMed ID: 26976989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Potential of Lymphocyte-C-Reactive Protein Ratio in Patients with Rectal Cancer Receiving Preoperative Chemoradiotherapy.
    Okugawa Y; Toiyama Y; Fujikawa H; Ide S; Yamamoto A; Omura Y; Yin C; Kusunoki K; Kusunoki Y; Yasuda H; Yokoe T; Hiro J; Ohi M; Kusunoki M
    J Gastrointest Surg; 2021 Feb; 25(2):492-502. PubMed ID: 32040814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte-to-C-Reactive Protein Ratio Is the Most Sensitive Inflammation-Based Prognostic Score in Patients With Unresectable Metastatic Colorectal Cancer.
    Nakamura Y; Shida D; Boku N; Yoshida T; Tanabe T; Takamizawa Y; Takashima A; Kanemitsu Y
    Dis Colon Rectum; 2021 Nov; 64(11):1331-1341. PubMed ID: 34623347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preoperative prediction model based on Lymphocyte-C-reactive protein ratio predicts postoperative anastomotic leakage in patients with colorectal carcinoma: a retrospective study.
    Zhong B; Lin ZY; Ma DD; Shang ZH; Shen YB; Zhang T; Zhang JX; Jin WD
    BMC Surg; 2022 Jul; 22(1):283. PubMed ID: 35870933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-Reactive Protein/Albumin Ratio Is an Independent Risk Factor for Recurrence and Survival Following Curative Resection of Stage I-III Colorectal Cancer in Older Patients.
    Bekki T; Shimomura M; Hattori M; Sato S; Watanabe A; Ishikawa S; Imaoka K; Ono K; Matsubara K; Mochizuki T; Akabane S; Yano T; Ohdan H
    Ann Surg Oncol; 2024 Jul; 31(7):4812-4821. PubMed ID: 38280961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.